![](/imgs/covers/am_cover.jpg)
|
Annals of African Medicine
Annals of African Medicine Society
ISSN: 1596-3519
Vol. 8, No. 2, 2009, pp. 76-80
|
Bioline Code: am09018
Full paper language: English
Document type: Review Article
Document available free of charge
|
|
Annals of African Medicine, Vol. 8, No. 2, 2009, pp. 76-80
en |
The use of magnesium sulphate for the treatment of severe pre-eclampsia and eclampsia
Tukur, Jamil
Abstract
Background : Pre-eclampsia and eclampsia are important causes of maternal and perinatal morbidity and mortality in the developing countries. There is need to provide the most effective management to pre-eclamptic and eclamptic patients. There is now evidence that magnesium sulphate is the most effective anticonvulsant.
Method : In this article, a literature review was made on the contribution of pre-eclampsia and eclampsia to maternal mortality and how it can be curtailed by the use of magnesium sulphate.
Results : The drug is administered by the Pritchard or Zuspan regimen, although modifications in the two protocols have been reported.
Conclusion : A Nigerian national protocol has been developed on its use. There is need for further training of health workers on how to use this important drug.
Keywords
Eclampsia; maternal mortality; magnesium sulphate; training
|
|
© Copyright 2009 Annals of African Medicine. Alternative site location: http://www.annalsafrmed.org
|
|